Abstract
Inflammasome activation leads to caspase-1 activation, which causes the maturation and secretion of pro-IL-1βand pro-IL-18 among other substrates. A subgroup of the NLR (nucleotide-binding domain, leucine-rich repeat containing) proteins are key mediators of the inflammasome. Studies of gene-deficient mice and cells have implicated NLR inflammasomes in a host of responses to a wide range of microbial pathogens, inflammatory diseases, cancer, and metabolic and autoimmune disorders. Determining exactly how the inflammasome is activated in these diseases and disease models remains a challenge. This review presents and integrates recent progress in the field.
Original language | English |
---|---|
Pages (from-to) | 707-735 |
Number of pages | 29 |
Journal | Annual review of immunology |
Volume | 29 |
DOIs | |
State | Published - Apr 23 2011 |
Keywords
- IL-1β
- cancer
- caspase-1
- innate immunity
- metabolic diseases